Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov 17;16(11):e253930.
doi: 10.1136/bcr-2022-253930.

IgG4-related disease of the mastoid: a rare presentation of a novel diagnosis

Affiliations
Case Reports

IgG4-related disease of the mastoid: a rare presentation of a novel diagnosis

Mohit Achanta et al. BMJ Case Rep. .

Abstract

IgG4-related disease (IgG4-RD) is an inflammatory condition characterised by infiltration of tissue by IgG4-positive plasma cells. This is the seventh reported case of IgG4-RD affecting the mastoid and informs clinicians in diagnosing patients affected by this rare condition.A woman in her 20s presented with unilateral otalgia, hearing loss and vertigo. She deteriorated despite antibiotic therapy and cross-sectional imaging revealed a destructive extra-axial lesion of the mastoid cells. Biopsy confirmed a diagnosis of IgG4-RD. She was successfully treated with prednisolone and azathioprine.Inflammatory conditions should be considered in patients with persistent middle ear symptoms after infection and malignancy are excluded. Delays in diagnosis can lead to irreversible mass effects and may occur as current diagnostic criteria exclude mastoid-specific features.IgG4-RD remains a rare diagnosis. To avoid significant effects on a patients' quality of life, prompt multidisciplinary treatment is vital alongside development of diagnostic criteria specific to otolaryngology.

Keywords: Head and neck surgery; Immunology; Otolaryngology / ENT; Radiology; Rheumatology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of Igg4 related disease. BMJ 2020;369. 10.1136/bmj.m1067 - DOI - PubMed
    1. Deshpande V, Zen Y, Chan JK, et al. . Consensus statement on the pathology of Igg4-related disease. Mod Pathol 2012;25:1181–92. 10.1038/modpathol.2012.72 - DOI - PubMed
    1. Wallace ZS, Naden RP, Chari S, et al. . The 2019 American college of rheumatology/European league against rheumatism classification criteria for Igg4-related disease. Ann Rheum Dis 2020;79:77–87. 10.1136/annrheumdis-2019-216561 - DOI - PubMed
    1. Maughan EF, Michaels J, Miller B, et al. . Primary immunoglobulin G4-related Laryngeal disease: a case series and review of literature. Clin Med Insights Case Rep 2020;13. 10.1177/1179547620960197 - DOI - PMC - PubMed
    1. Vuncannon JR, Panella NJ, Magliocca KR, et al. . Diagnostic challenges in a case of Igg4-RD affecting the temporal bone. Ann Otol Rhinol Laryngol 2017;126:241–4. 10.1177/0003489416678009 - DOI - PubMed

Publication types

Substances